Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019
LONDON, Feb. 3, 2015 /PRNewswire/ -- This report covers the market analysis for various drugs, devices and treatment technologies used in assistance and to control human reproduction. The stakeholders for this study include manufacturers and providers of contraceptive technologies and infertility solutions.
The market overview section of the report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global human reproductive technologies market.
The global human reproductive technologies market is categorized on the basis of various infertility treatments and contraceptive technologies. The infertility technologies market is analyzed in this report with respect to drugs as well as types of treatment procedures. With respect to drugs, the report includes leading brands (by sales) from three major classes, namely, gonadotropins, androgens and erectile dysfunction. The drug brands analyzed in this study include Gonal-f, Follistim AQ, AndroGel, Testim, Viagra, Cialis and Levitra/Staxyn. The market revenue and forecast for each brand has been provided for the period 2011 to 2019 in terms of USD million, along with the CAGR for the forecast period 2013 to 2019. The types of infertility treatment procedures studied in the report include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), zygote intrafallopian transfer (ZIFT), gamete intrafallopian transfer (GIFT) and intrauterine insemination (IUI). This section provides the global number of procedures performed historically for 2011 and 2012 along with the forecast for the period 2013 to 2019.
The contraceptive technologies market is classified into contraceptive drugs and devices. The contraceptive drugs market includes oral contraceptive pills, contraceptive injectables and topical contraceptives, while the contraceptive devices market is segmented into male contraceptive devices (condoms) and female contraceptive devices. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019. The market revenue has been forecast for the period 2013 to 2019, considering 2012 as the base year.
In terms of geographical distribution, the global human reproductive technologies market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section includes market revenue (2011 – 2019) and forecast (2013 – 2019) for the infertility treatment and contraceptive technologies markets in each regional market, in terms of USD million. The study further offers recommendations and highlights of the market, which would be useful for the present and new market players to sustain and grow in the global human reproductive technologies market.
This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include, Bayer Healthcare AG, Church & Dwight, Co. Inc., Boston Scientific Corporation, Ferring International Center S.A., Merck KGaA and Teva Pharmaceutical Industries, Ltd.
The global human reproductive technologies market is categorized into the following segments:
Human Reproductive Technologies Market, by Infertility Drugs
Gonal-f (recombinant follitropin alfa)
Follistim AQ (follitropin beta)
AndroGel (testosterone)
Testim (testosterone)
Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)
Human Reproductive Technologies Market, by Infertility Procedures
In Vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)
Zygote Intrafallopian Transfer (ZIFT)
Gamete Intrafallopian Transfer (GIFT)
Intrauterine Insemination (IUI)
Human Reproductive Technologies Market, by Contraceptive Technologies
Drugs
Oral Contraceptive Pills
Contraceptive Injectables
Topical Contraceptives
Devices
Male Contraceptive Devices (Male Condoms)
Female Contraceptive Devices
Human Reproductive Technologies Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Download the full report: https://www.reportbuyer.com/product/2107709/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article